In addition, the authors thank Novo Nordisk A/S for their contribution to the study design, data management, and data analysis, Sayeh Tadayon (Novo Nordisk) for her review and input to the manuscript, and Flavia Sciota, PhD (AXON Communications) for medical writing and editorial assistance
A 52semanas se observa reduccin del volumen circulante y de la presin arterial, en relacin con la reduccin de adipoquinas y aldosterona, acompaado de disminucin de albuminuria y aumento de filtrado glomerular respecto a placebo, sugiriendo beneficio renal aadido47
It supports immune function, promotes healthy digestion, and helps improve energy levels
Are you drinking enough water
The complete titration schedule from clinical trials
GLP-1 medications may be important tools for selected patients, but heart health still requires a complete medical strategy